Standard BioTools Inc. Other Noncash Income (Expense)
Standard BioTools Inc. (LAB) reported Other Noncash Income (Expense) of $176.00 thousand for the 9-month period ending 2019-09-30, per its 10-Q filed 2019-11-08.
Discontinued › Cash Flow › Operating Activities
us-gaap:OtherNoncashIncomeExpense · last filed 2019-11-08
- Standard BioTools Inc. other noncash income (expense) for the quarter ending 2019-09-30 was $88.00K.
- Standard BioTools Inc. other noncash income (expense) for the quarter ending 2019-06-30 was $63.00K.
- Standard BioTools Inc. other noncash income (expense) for the quarter ending 2019-03-31 was $25.00K, a 95.56% decline year-over-year.
- Standard BioTools Inc. other noncash income (expense) for the quarter ending 2018-09-30 was -$81.00K, a 168.64% decline year-over-year.
| Period end | Other Noncash Income (Expense) 3 month | Other Noncash Income (Expense) 3 month as first filed | Other Noncash Income (Expense) 6 month | Other Noncash Income (Expense) 9 month | Other Noncash Income (Expense) 9 month as first filed |
|---|---|---|---|---|---|
| 2019-09-30 | $88.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $151.00K derived: sum of 2 quarters · filed 2019-11-08 | $176.00K 10-Q · filed 2019-11-08 | ||
| 2019-06-30 | $63.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $88.00K 10-Q · filed 2019-08-07 | |||
| 2019-03-31 | $25.00K 10-Q · filed 2019-05-07 | ||||
| 2018-09-30 | -$81.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | -$603.00K derived: sum of 2 quarters · filed 2019-11-08 | -$40.00K 10-Q · filed 2019-11-08 | ||
| 2018-06-30 | -$522.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $41.00K 10-Q · filed 2019-08-07 | |||
| 2018-03-31 | $563.00K 10-Q · filed 2019-05-07 | $58.00K 10-Q · filed 2018-05-08 | |||
| 2017-09-30 | $118.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $409.00K derived: sum of 2 quarters · filed 2018-11-06 | $535.00K 10-Q · filed 2018-11-06 | ||
| 2017-06-30 | $291.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | $417.00K 10-Q · filed 2018-08-08 | |||
| 2017-03-31 | $126.00K 10-Q · filed 2018-05-08 | ||||
| 2016-09-30 | -$38.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | -$365.00K derived: sum of 2 quarters · filed 2017-11-07 | -$592.00K 10-Q · filed 2017-11-07 | ||
| 2016-06-30 | -$327.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | -$554.00K 10-Q · filed 2017-08-08 | |||
| 2016-03-31 | -$227.00K 10-Q · filed 2017-05-09 | ||||
| 2015-09-30 | $7.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | -$223.00K derived: sum of 2 quarters · filed 2016-11-09 | -$223.00K 10-Q · filed 2016-11-09 | -$136.00K 10-Q · filed 2015-11-09 | |
| 2015-06-30 | -$230.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | -$230.00K 10-Q · filed 2016-08-09 | |||
| 2015-03-31 | $0.00 10-Q · filed 2016-05-09 | ||||
| 2014-09-30 | -$16.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | -$83.00K 10-Q · filed 2015-11-09 | |||
| 2014-06-30 | -$67.00K 10-Q · filed 2015-08-10 | ||||
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | -$29.00K derived: sum of 2 quarters · filed 2014-11-06 | -$29.00K 10-Q · filed 2014-11-06 | ||
| 2013-06-30 | -$29.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-04 | -$29.00K 10-Q · filed 2014-08-04 | |||
| 2013-03-31 | $0.00 10-Q · filed 2013-05-09 | ||||
| 2012-09-30 | -$1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | $22.00K derived: sum of 2 quarters · filed 2013-11-07 | -$26.00K 10-Q · filed 2013-11-07 | ||
| 2012-06-30 | $23.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-07 | -$25.00K 10-Q · filed 2013-08-07 | |||
| 2012-03-31 | -$48.00K 10-Q · filed 2013-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |